nodes	percent_of_prediction	percent_of_DWPC	metapath
Pentoxifylline—Cholestasis intrahepatic—Furosemide—dilated cardiomyopathy	0.0777	0.123	CcSEcCtD
Pentoxifylline—PDE5A—pulmonary artery—dilated cardiomyopathy	0.0683	0.389	CbGeAlD
Pentoxifylline—Abdominal bloating—Furosemide—dilated cardiomyopathy	0.0171	0.027	CcSEcCtD
Pentoxifylline—NT5E—heart—dilated cardiomyopathy	0.0144	0.0817	CbGeAlD
Pentoxifylline—Cramps of lower extremities—Spironolactone—dilated cardiomyopathy	0.0138	0.0217	CcSEcCtD
Pentoxifylline—ADORA1—myocardium—dilated cardiomyopathy	0.0127	0.072	CbGeAlD
Pentoxifylline—NT5E—cardiac atrium—dilated cardiomyopathy	0.0123	0.0699	CbGeAlD
Pentoxifylline—PDE4A—heart—dilated cardiomyopathy	0.011	0.0624	CbGeAlD
Pentoxifylline—Sleep disturbance—Lisinopril—dilated cardiomyopathy	0.0109	0.0172	CcSEcCtD
Pentoxifylline—Cholestasis—Furosemide—dilated cardiomyopathy	0.0107	0.0169	CcSEcCtD
Pentoxifylline—PDE4B—cardiac ventricle—dilated cardiomyopathy	0.00995	0.0567	CbGeAlD
Pentoxifylline—PDE4B—myocardium—dilated cardiomyopathy	0.00936	0.0533	CbGeAlD
Pentoxifylline—PDE5A—heart—dilated cardiomyopathy	0.00932	0.053	CbGeAlD
Pentoxifylline—Heartburn—Lisinopril—dilated cardiomyopathy	0.00888	0.014	CcSEcCtD
Pentoxifylline—ADORA1—heart—dilated cardiomyopathy	0.00883	0.0503	CbGeAlD
Pentoxifylline—Influenza-like symptoms—Lisinopril—dilated cardiomyopathy	0.00856	0.0135	CcSEcCtD
Pentoxifylline—Throat sore—Lisinopril—dilated cardiomyopathy	0.00848	0.0134	CcSEcCtD
Pentoxifylline—Laryngitis—Lisinopril—dilated cardiomyopathy	0.00848	0.0134	CcSEcCtD
Pentoxifylline—Oropharyngeal discomfort—Lisinopril—dilated cardiomyopathy	0.0084	0.0133	CcSEcCtD
Pentoxifylline—Drowsiness—Spironolactone—dilated cardiomyopathy	0.00838	0.0132	CcSEcCtD
Pentoxifylline—Aplastic anaemia—Furosemide—dilated cardiomyopathy	0.00765	0.0121	CcSEcCtD
Pentoxifylline—ADORA1—cardiac atrium—dilated cardiomyopathy	0.00756	0.043	CbGeAlD
Pentoxifylline—Cramps of lower extremities—Furosemide—dilated cardiomyopathy	0.00748	0.0118	CcSEcCtD
Pentoxifylline—Lightheadedness—Furosemide—dilated cardiomyopathy	0.00729	0.0115	CcSEcCtD
Pentoxifylline—Oropharyngeal pain—Lisinopril—dilated cardiomyopathy	0.00672	0.0106	CcSEcCtD
Pentoxifylline—Swelling—Furosemide—dilated cardiomyopathy	0.0067	0.0106	CcSEcCtD
Pentoxifylline—Vascular purpura—Furosemide—dilated cardiomyopathy	0.00661	0.0104	CcSEcCtD
Pentoxifylline—PDE4B—heart—dilated cardiomyopathy	0.00653	0.0372	CbGeAlD
Pentoxifylline—Muscle spasms—Spironolactone—dilated cardiomyopathy	0.00629	0.00994	CcSEcCtD
Pentoxifylline—Thirst—Furosemide—dilated cardiomyopathy	0.00621	0.00981	CcSEcCtD
Pentoxifylline—Purpura—Furosemide—dilated cardiomyopathy	0.00613	0.00969	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Furosemide—dilated cardiomyopathy	0.00611	0.00965	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Spironolactone—dilated cardiomyopathy	0.00607	0.00959	CcSEcCtD
Pentoxifylline—Influenza like illness—Lisinopril—dilated cardiomyopathy	0.00594	0.00937	CcSEcCtD
Pentoxifylline—Salivary hypersecretion—Lisinopril—dilated cardiomyopathy	0.00594	0.00937	CcSEcCtD
Pentoxifylline—Malaise—Spironolactone—dilated cardiomyopathy	0.0059	0.00932	CcSEcCtD
Pentoxifylline—Leukopenia—Spironolactone—dilated cardiomyopathy	0.00586	0.00925	CcSEcCtD
Pentoxifylline—PDE4B—cardiac atrium—dilated cardiomyopathy	0.00559	0.0318	CbGeAlD
Pentoxifylline—Discomfort—Spironolactone—dilated cardiomyopathy	0.00551	0.0087	CcSEcCtD
Pentoxifylline—Lightheadedness—Lisinopril—dilated cardiomyopathy	0.00547	0.00864	CcSEcCtD
Pentoxifylline—Confusional state—Spironolactone—dilated cardiomyopathy	0.00539	0.00851	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Spironolactone—dilated cardiomyopathy	0.00534	0.00844	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Spironolactone—dilated cardiomyopathy	0.00523	0.00826	CcSEcCtD
Pentoxifylline—Abdominal distension—Furosemide—dilated cardiomyopathy	0.00514	0.00813	CcSEcCtD
Pentoxifylline—Sleep disorder—Lisinopril—dilated cardiomyopathy	0.00513	0.00809	CcSEcCtD
Pentoxifylline—Nasal congestion—Lisinopril—dilated cardiomyopathy	0.00487	0.00769	CcSEcCtD
Pentoxifylline—Somnolence—Spironolactone—dilated cardiomyopathy	0.00475	0.0075	CcSEcCtD
Pentoxifylline—Anaphylactoid reaction—Lisinopril—dilated cardiomyopathy	0.00458	0.00724	CcSEcCtD
Pentoxifylline—Drowsiness—Furosemide—dilated cardiomyopathy	0.00456	0.0072	CcSEcCtD
Pentoxifylline—Feeling abnormal—Spironolactone—dilated cardiomyopathy	0.0044	0.00695	CcSEcCtD
Pentoxifylline—Sweating—Furosemide—dilated cardiomyopathy	0.00437	0.0069	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Furosemide—dilated cardiomyopathy	0.00431	0.00681	CcSEcCtD
Pentoxifylline—Urticaria—Spironolactone—dilated cardiomyopathy	0.00424	0.0067	CcSEcCtD
Pentoxifylline—Body temperature increased—Spironolactone—dilated cardiomyopathy	0.00422	0.00667	CcSEcCtD
Pentoxifylline—Hypersensitivity—Spironolactone—dilated cardiomyopathy	0.00394	0.00622	CcSEcCtD
Pentoxifylline—Pruritus—Spironolactone—dilated cardiomyopathy	0.00378	0.00597	CcSEcCtD
Pentoxifylline—Bronchospasm—Lisinopril—dilated cardiomyopathy	0.00377	0.00596	CcSEcCtD
Pentoxifylline—Angina pectoris—Lisinopril—dilated cardiomyopathy	0.00374	0.0059	CcSEcCtD
Pentoxifylline—Immune system disorder—Furosemide—dilated cardiomyopathy	0.00369	0.00584	CcSEcCtD
Pentoxifylline—Diarrhoea—Spironolactone—dilated cardiomyopathy	0.00365	0.00577	CcSEcCtD
Pentoxifylline—Arrhythmia—Furosemide—dilated cardiomyopathy	0.00365	0.00577	CcSEcCtD
Pentoxifylline—Pancytopenia—Lisinopril—dilated cardiomyopathy	0.00364	0.00575	CcSEcCtD
Pentoxifylline—Erythema—Furosemide—dilated cardiomyopathy	0.00356	0.00562	CcSEcCtD
Pentoxifylline—Dizziness—Spironolactone—dilated cardiomyopathy	0.00353	0.00558	CcSEcCtD
Pentoxifylline—Flatulence—Furosemide—dilated cardiomyopathy	0.00351	0.00554	CcSEcCtD
Pentoxifylline—Dysgeusia—Furosemide—dilated cardiomyopathy	0.00349	0.00551	CcSEcCtD
Pentoxifylline—Muscle spasms—Furosemide—dilated cardiomyopathy	0.00342	0.00541	CcSEcCtD
Pentoxifylline—Vomiting—Spironolactone—dilated cardiomyopathy	0.0034	0.00536	CcSEcCtD
Pentoxifylline—Rash—Spironolactone—dilated cardiomyopathy	0.00337	0.00532	CcSEcCtD
Pentoxifylline—Dermatitis—Spironolactone—dilated cardiomyopathy	0.00336	0.00531	CcSEcCtD
Pentoxifylline—Vision blurred—Furosemide—dilated cardiomyopathy	0.00336	0.0053	CcSEcCtD
Pentoxifylline—Headache—Spironolactone—dilated cardiomyopathy	0.00335	0.00529	CcSEcCtD
Pentoxifylline—Jaundice—Lisinopril—dilated cardiomyopathy	0.00333	0.00526	CcSEcCtD
Pentoxifylline—Anaemia—Furosemide—dilated cardiomyopathy	0.00329	0.0052	CcSEcCtD
Pentoxifylline—Sweating—Lisinopril—dilated cardiomyopathy	0.00328	0.00518	CcSEcCtD
Pentoxifylline—Agitation—Furosemide—dilated cardiomyopathy	0.00327	0.00517	CcSEcCtD
Pentoxifylline—Hepatobiliary disease—Lisinopril—dilated cardiomyopathy	0.00323	0.00511	CcSEcCtD
Pentoxifylline—Epistaxis—Lisinopril—dilated cardiomyopathy	0.00322	0.00509	CcSEcCtD
Pentoxifylline—Leukopenia—Furosemide—dilated cardiomyopathy	0.00319	0.00503	CcSEcCtD
Pentoxifylline—Nausea—Spironolactone—dilated cardiomyopathy	0.00317	0.00501	CcSEcCtD
Pentoxifylline—Hepatitis—Lisinopril—dilated cardiomyopathy	0.00307	0.00485	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Furosemide—dilated cardiomyopathy	0.00301	0.00475	CcSEcCtD
Pentoxifylline—Dry mouth—Furosemide—dilated cardiomyopathy	0.00296	0.00468	CcSEcCtD
Pentoxifylline—Confusional state—Furosemide—dilated cardiomyopathy	0.00293	0.00463	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Furosemide—dilated cardiomyopathy	0.00291	0.00459	CcSEcCtD
Pentoxifylline—Shock—Furosemide—dilated cardiomyopathy	0.00286	0.00452	CcSEcCtD
Pentoxifylline—Flushing—Lisinopril—dilated cardiomyopathy	0.00285	0.0045	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Furosemide—dilated cardiomyopathy	0.00285	0.00449	CcSEcCtD
Pentoxifylline—Skin disorder—Furosemide—dilated cardiomyopathy	0.00282	0.00446	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Furosemide—dilated cardiomyopathy	0.00281	0.00444	CcSEcCtD
Pentoxifylline—Anorexia—Furosemide—dilated cardiomyopathy	0.00277	0.00438	CcSEcCtD
Pentoxifylline—Arrhythmia—Lisinopril—dilated cardiomyopathy	0.00274	0.00433	CcSEcCtD
Pentoxifylline—Hypotension—Furosemide—dilated cardiomyopathy	0.00272	0.00429	CcSEcCtD
Pentoxifylline—Erythema—Lisinopril—dilated cardiomyopathy	0.00267	0.00422	CcSEcCtD
Pentoxifylline—Flatulence—Lisinopril—dilated cardiomyopathy	0.00263	0.00416	CcSEcCtD
Pentoxifylline—Tension—Lisinopril—dilated cardiomyopathy	0.00262	0.00414	CcSEcCtD
Pentoxifylline—Dysgeusia—Lisinopril—dilated cardiomyopathy	0.00262	0.00413	CcSEcCtD
Pentoxifylline—Nervousness—Lisinopril—dilated cardiomyopathy	0.00259	0.0041	CcSEcCtD
Pentoxifylline—Back pain—Lisinopril—dilated cardiomyopathy	0.00258	0.00408	CcSEcCtD
Pentoxifylline—Somnolence—Furosemide—dilated cardiomyopathy	0.00258	0.00408	CcSEcCtD
Pentoxifylline—Muscle spasms—Lisinopril—dilated cardiomyopathy	0.00257	0.00406	CcSEcCtD
Pentoxifylline—Decreased appetite—Furosemide—dilated cardiomyopathy	0.00253	0.00399	CcSEcCtD
Pentoxifylline—Vision blurred—Lisinopril—dilated cardiomyopathy	0.00252	0.00398	CcSEcCtD
Pentoxifylline—Tremor—Lisinopril—dilated cardiomyopathy	0.0025	0.00395	CcSEcCtD
Pentoxifylline—Constipation—Furosemide—dilated cardiomyopathy	0.00249	0.00392	CcSEcCtD
Pentoxifylline—Ill-defined disorder—Lisinopril—dilated cardiomyopathy	0.00248	0.00392	CcSEcCtD
Pentoxifylline—Anaemia—Lisinopril—dilated cardiomyopathy	0.00247	0.0039	CcSEcCtD
Pentoxifylline—Angioedema—Lisinopril—dilated cardiomyopathy	0.00244	0.00386	CcSEcCtD
Pentoxifylline—Malaise—Lisinopril—dilated cardiomyopathy	0.00241	0.00381	CcSEcCtD
Pentoxifylline—Feeling abnormal—Furosemide—dilated cardiomyopathy	0.00239	0.00378	CcSEcCtD
Pentoxifylline—Leukopenia—Lisinopril—dilated cardiomyopathy	0.00239	0.00378	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Furosemide—dilated cardiomyopathy	0.00238	0.00375	CcSEcCtD
Pentoxifylline—Palpitations—Lisinopril—dilated cardiomyopathy	0.00236	0.00373	CcSEcCtD
Pentoxifylline—Urticaria—Furosemide—dilated cardiomyopathy	0.00231	0.00365	CcSEcCtD
Pentoxifylline—Abdominal pain—Furosemide—dilated cardiomyopathy	0.0023	0.00363	CcSEcCtD
Pentoxifylline—Body temperature increased—Furosemide—dilated cardiomyopathy	0.0023	0.00363	CcSEcCtD
Pentoxifylline—Myalgia—Lisinopril—dilated cardiomyopathy	0.00227	0.00359	CcSEcCtD
Pentoxifylline—Chest pain—Lisinopril—dilated cardiomyopathy	0.00227	0.00359	CcSEcCtD
Pentoxifylline—Anxiety—Lisinopril—dilated cardiomyopathy	0.00227	0.00358	CcSEcCtD
Pentoxifylline—Unspecified disorder of skin and subcutaneous tissue—Lisinopril—dilated cardiomyopathy	0.00226	0.00357	CcSEcCtD
Pentoxifylline—Discomfort—Lisinopril—dilated cardiomyopathy	0.00225	0.00355	CcSEcCtD
Pentoxifylline—Dry mouth—Lisinopril—dilated cardiomyopathy	0.00222	0.00351	CcSEcCtD
Pentoxifylline—Confusional state—Lisinopril—dilated cardiomyopathy	0.0022	0.00347	CcSEcCtD
Pentoxifylline—Oedema—Lisinopril—dilated cardiomyopathy	0.00218	0.00344	CcSEcCtD
Pentoxifylline—Anaphylactic shock—Lisinopril—dilated cardiomyopathy	0.00218	0.00344	CcSEcCtD
Pentoxifylline—Infection—Lisinopril—dilated cardiomyopathy	0.00217	0.00342	CcSEcCtD
Pentoxifylline—Shock—Lisinopril—dilated cardiomyopathy	0.00215	0.00339	CcSEcCtD
Pentoxifylline—Hypersensitivity—Furosemide—dilated cardiomyopathy	0.00214	0.00338	CcSEcCtD
Pentoxifylline—Thrombocytopenia—Lisinopril—dilated cardiomyopathy	0.00213	0.00337	CcSEcCtD
Pentoxifylline—Tachycardia—Lisinopril—dilated cardiomyopathy	0.00213	0.00336	CcSEcCtD
Pentoxifylline—Skin disorder—Lisinopril—dilated cardiomyopathy	0.00212	0.00335	CcSEcCtD
Pentoxifylline—Hyperhidrosis—Lisinopril—dilated cardiomyopathy	0.00211	0.00333	CcSEcCtD
Pentoxifylline—Asthenia—Furosemide—dilated cardiomyopathy	0.00209	0.00329	CcSEcCtD
Pentoxifylline—Anorexia—Lisinopril—dilated cardiomyopathy	0.00208	0.00328	CcSEcCtD
Pentoxifylline—Pruritus—Furosemide—dilated cardiomyopathy	0.00206	0.00325	CcSEcCtD
Pentoxifylline—Hypotension—Lisinopril—dilated cardiomyopathy	0.00204	0.00322	CcSEcCtD
Pentoxifylline—Diarrhoea—Furosemide—dilated cardiomyopathy	0.00199	0.00314	CcSEcCtD
Pentoxifylline—Musculoskeletal discomfort—Lisinopril—dilated cardiomyopathy	0.00199	0.00314	CcSEcCtD
Pentoxifylline—Insomnia—Lisinopril—dilated cardiomyopathy	0.00197	0.00311	CcSEcCtD
Pentoxifylline—Dyspnoea—Lisinopril—dilated cardiomyopathy	0.00194	0.00307	CcSEcCtD
Pentoxifylline—Somnolence—Lisinopril—dilated cardiomyopathy	0.00194	0.00306	CcSEcCtD
Pentoxifylline—Dizziness—Furosemide—dilated cardiomyopathy	0.00192	0.00304	CcSEcCtD
Pentoxifylline—Dyspepsia—Lisinopril—dilated cardiomyopathy	0.00192	0.00303	CcSEcCtD
Pentoxifylline—Decreased appetite—Lisinopril—dilated cardiomyopathy	0.0019	0.00299	CcSEcCtD
Pentoxifylline—Constipation—Lisinopril—dilated cardiomyopathy	0.00186	0.00294	CcSEcCtD
Pentoxifylline—Vomiting—Furosemide—dilated cardiomyopathy	0.00185	0.00292	CcSEcCtD
Pentoxifylline—Rash—Furosemide—dilated cardiomyopathy	0.00183	0.00289	CcSEcCtD
Pentoxifylline—Dermatitis—Furosemide—dilated cardiomyopathy	0.00183	0.00289	CcSEcCtD
Pentoxifylline—Headache—Furosemide—dilated cardiomyopathy	0.00182	0.00288	CcSEcCtD
Pentoxifylline—Feeling abnormal—Lisinopril—dilated cardiomyopathy	0.0018	0.00284	CcSEcCtD
Pentoxifylline—Gastrointestinal pain—Lisinopril—dilated cardiomyopathy	0.00178	0.00282	CcSEcCtD
Pentoxifylline—Urticaria—Lisinopril—dilated cardiomyopathy	0.00173	0.00274	CcSEcCtD
Pentoxifylline—Nausea—Furosemide—dilated cardiomyopathy	0.00173	0.00273	CcSEcCtD
Pentoxifylline—Abdominal pain—Lisinopril—dilated cardiomyopathy	0.00172	0.00272	CcSEcCtD
Pentoxifylline—Body temperature increased—Lisinopril—dilated cardiomyopathy	0.00172	0.00272	CcSEcCtD
Pentoxifylline—Hypersensitivity—Lisinopril—dilated cardiomyopathy	0.00161	0.00254	CcSEcCtD
Pentoxifylline—Asthenia—Lisinopril—dilated cardiomyopathy	0.00156	0.00247	CcSEcCtD
Pentoxifylline—Pruritus—Lisinopril—dilated cardiomyopathy	0.00154	0.00244	CcSEcCtD
Pentoxifylline—Diarrhoea—Lisinopril—dilated cardiomyopathy	0.00149	0.00236	CcSEcCtD
Pentoxifylline—NT5E—Metabolism—SDHA—dilated cardiomyopathy	0.00144	0.00755	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—ADRB1—dilated cardiomyopathy	0.00144	0.00755	CbGpPWpGaD
Pentoxifylline—Dizziness—Lisinopril—dilated cardiomyopathy	0.00144	0.00228	CcSEcCtD
Pentoxifylline—Vomiting—Lisinopril—dilated cardiomyopathy	0.00139	0.00219	CcSEcCtD
Pentoxifylline—Rash—Lisinopril—dilated cardiomyopathy	0.00137	0.00217	CcSEcCtD
Pentoxifylline—Dermatitis—Lisinopril—dilated cardiomyopathy	0.00137	0.00217	CcSEcCtD
Pentoxifylline—Headache—Lisinopril—dilated cardiomyopathy	0.00137	0.00216	CcSEcCtD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00136	0.0071	CbGpPWpGaD
Pentoxifylline—Nausea—Lisinopril—dilated cardiomyopathy	0.0013	0.00205	CcSEcCtD
Pentoxifylline—CYP1A2—Melatonin metabolism and effects—ADRB1—dilated cardiomyopathy	0.00128	0.0067	CbGpPWpGaD
Pentoxifylline—PDE4B—Myometrial Relaxation and Contraction Pathways—GJA1—dilated cardiomyopathy	0.00127	0.00667	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00126	0.0066	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—CXCL2—dilated cardiomyopathy	0.00124	0.00651	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—AGTR2—dilated cardiomyopathy	0.00124	0.00651	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00122	0.0064	CbGpPWpGaD
Pentoxifylline—ADORA2A—G alpha (s) signalling events—ADRB2—dilated cardiomyopathy	0.00117	0.00611	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.00116	0.00609	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.00116	0.00609	CbGpPWpGaD
Pentoxifylline—ADORA2A—Monoamine Transport—TNF—dilated cardiomyopathy	0.00116	0.00607	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—CXCR3—dilated cardiomyopathy	0.00116	0.00605	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.00115	0.00604	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00108	0.00566	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.00107	0.00562	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.00105	0.00548	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.00104	0.00546	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.00104	0.00544	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000991	0.00518	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000989	0.00517	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000989	0.00517	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—PSEN2—dilated cardiomyopathy	0.000925	0.00484	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00092	0.00481	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000895	0.00468	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR2—dilated cardiomyopathy	0.000891	0.00466	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000891	0.00466	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000888	0.00464	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000886	0.00463	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000886	0.00463	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000849	0.00444	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.000842	0.00441	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—ITGB1—dilated cardiomyopathy	0.000837	0.00438	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—CXCR3—dilated cardiomyopathy	0.000829	0.00434	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000824	0.00431	CbGpPWpGaD
Pentoxifylline—ADORA1—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000814	0.00426	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB1—dilated cardiomyopathy	0.000803	0.0042	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000798	0.00417	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCL2—dilated cardiomyopathy	0.000764	0.004	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR2—dilated cardiomyopathy	0.000764	0.004	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000761	0.00398	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000753	0.00394	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000753	0.00394	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000722	0.00378	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—CD36—dilated cardiomyopathy	0.000714	0.00373	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—CXCR3—dilated cardiomyopathy	0.00071	0.00371	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.0007	0.00366	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB1—dilated cardiomyopathy	0.000688	0.0036	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—AGTR1—dilated cardiomyopathy	0.000685	0.00359	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000681	0.00356	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000678	0.00355	CbGpPWpGaD
Pentoxifylline—ADORA1—G alpha (i) signalling events—AGT—dilated cardiomyopathy	0.000673	0.00352	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—RAC1—dilated cardiomyopathy	0.000672	0.00352	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCRs, Class A Rhodopsin-like—ADRB2—dilated cardiomyopathy	0.00065	0.0034	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000646	0.00338	CbGpPWpGaD
Pentoxifylline—ADORA2B—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.00063	0.00329	CbGpPWpGaD
Pentoxifylline—ADORA2A—Circadian rythm related genes—FAS—dilated cardiomyopathy	0.000629	0.00329	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—CD36—dilated cardiomyopathy	0.000591	0.00309	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGTR1—dilated cardiomyopathy	0.000587	0.00307	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—AGTR2—dilated cardiomyopathy	0.000582	0.00304	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCL2—dilated cardiomyopathy	0.000582	0.00304	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000579	0.00303	CbGpPWpGaD
Pentoxifylline—CYP1A2—Arachidonic acid metabolism—GPX1—dilated cardiomyopathy	0.000567	0.00297	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—ADRB2—dilated cardiomyopathy	0.000557	0.00291	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.00055	0.00287	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—CXCR3—dilated cardiomyopathy	0.000541	0.00283	CbGpPWpGaD
Pentoxifylline—ADORA1—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000535	0.0028	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—ADRB1—dilated cardiomyopathy	0.000524	0.00274	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000501	0.00262	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000501	0.00262	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000479	0.00251	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000465	0.00243	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—RAC1—dilated cardiomyopathy	0.000465	0.00243	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000455	0.00238	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000455	0.00238	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000455	0.00238	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000455	0.00238	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000451	0.00236	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—AGTR1—dilated cardiomyopathy	0.000447	0.00234	CbGpPWpGaD
Pentoxifylline—PDE5A—Hemostasis—RAF1—dilated cardiomyopathy	0.000446	0.00233	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000426	0.00223	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000426	0.00223	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—ADRB2—dilated cardiomyopathy	0.000424	0.00222	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000423	0.00221	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000423	0.00221	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000421	0.0022	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000421	0.0022	CbGpPWpGaD
Pentoxifylline—ADORA2A—Class A/1 (Rhodopsin-like receptors)—AGT—dilated cardiomyopathy	0.000413	0.00216	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000413	0.00216	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000413	0.00216	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000409	0.00214	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000409	0.00214	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000408	0.00213	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—RAF1—dilated cardiomyopathy	0.000401	0.0021	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000396	0.00207	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—GPX1—dilated cardiomyopathy	0.000392	0.00205	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000391	0.00205	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000387	0.00202	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000387	0.00202	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000385	0.00201	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000384	0.00201	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000383	0.00201	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000382	0.002	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000382	0.002	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—CD36—dilated cardiomyopathy	0.000382	0.002	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000379	0.00198	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000372	0.00194	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—RAF1—dilated cardiomyopathy	0.000369	0.00193	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000365	0.00191	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000359	0.00188	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000355	0.00186	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—ANKRD1—dilated cardiomyopathy	0.000351	0.00184	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00035	0.00183	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.00035	0.00183	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000348	0.00182	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000344	0.0018	CbGpPWpGaD
Pentoxifylline—NT5E—Metabolism—AGT—dilated cardiomyopathy	0.000344	0.0018	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000332	0.00174	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000332	0.00173	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—TAZ—dilated cardiomyopathy	0.00033	0.00173	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCL2—dilated cardiomyopathy	0.000329	0.00172	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AGTR2—dilated cardiomyopathy	0.000329	0.00172	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000327	0.00171	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000323	0.00169	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000317	0.00166	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR ligand binding—AGT—dilated cardiomyopathy	0.000315	0.00165	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000311	0.00162	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—RAF1—dilated cardiomyopathy	0.000308	0.00161	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.000307	0.00161	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—CXCR3—dilated cardiomyopathy	0.000306	0.0016	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000302	0.00158	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000301	0.00158	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCL2—dilated cardiomyopathy	0.000298	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AGTR2—dilated cardiomyopathy	0.000298	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000297	0.00156	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRB1—dilated cardiomyopathy	0.000296	0.00155	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.000294	0.00154	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000284	0.00148	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000282	0.00148	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000279	0.00146	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—CXCR3—dilated cardiomyopathy	0.000277	0.00145	CbGpPWpGaD
Pentoxifylline—ADORA2A—NGF signalling via TRKA from the plasma membrane—EGFR—dilated cardiomyopathy	0.000275	0.00144	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000275	0.00144	CbGpPWpGaD
Pentoxifylline—ADORA2B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000271	0.00142	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRB1—dilated cardiomyopathy	0.000269	0.00141	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000269	0.0014	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000269	0.0014	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000257	0.00135	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000257	0.00135	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000257	0.00135	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000254	0.00133	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—EGFR—dilated cardiomyopathy	0.000253	0.00132	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—EGFR—dilated cardiomyopathy	0.000253	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AGTR1—dilated cardiomyopathy	0.000253	0.00132	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00025	0.00131	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000246	0.00129	CbGpPWpGaD
Pentoxifylline—PDE4A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000246	0.00129	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000244	0.00128	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000244	0.00128	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000242	0.00127	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000241	0.00126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—dilated cardiomyopathy	0.000241	0.00126	CbGpPWpGaD
Pentoxifylline—CYP1A2—Aryl Hydrocarbon Receptor—TNF—dilated cardiomyopathy	0.000241	0.00126	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—ADRB2—dilated cardiomyopathy	0.00024	0.00125	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000238	0.00125	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000234	0.00122	CbGpPWpGaD
Pentoxifylline—ADORA1—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.00023	0.00121	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AGTR1—dilated cardiomyopathy	0.00023	0.0012	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000228	0.00119	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000228	0.00119	CbGpPWpGaD
Pentoxifylline—PDE4B—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000228	0.00119	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000227	0.00119	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000226	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000226	0.00118	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000223	0.00117	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.00022	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000219	0.00115	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—ADRB2—dilated cardiomyopathy	0.000218	0.00114	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000216	0.00113	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000212	0.00111	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by NGF—EGFR—dilated cardiomyopathy	0.000211	0.00111	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.00021	0.0011	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000209	0.00109	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000207	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000207	0.00108	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000206	0.00108	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000203	0.00106	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—PSEN2—dilated cardiomyopathy	0.000199	0.00104	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000196	0.00102	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000188	0.000981	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—RAC1—dilated cardiomyopathy	0.000186	0.000974	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000178	0.000931	CbGpPWpGaD
Pentoxifylline—ADORA2A—GPCR downstream signaling—AGT—dilated cardiomyopathy	0.000178	0.00093	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCL2—dilated cardiomyopathy	0.000176	0.000922	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AGTR2—dilated cardiomyopathy	0.000176	0.000922	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000176	0.000919	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000174	0.000908	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000171	0.000893	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RAC1—dilated cardiomyopathy	0.000169	0.000884	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000168	0.000881	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000167	0.000872	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000165	0.000861	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—CXCR3—dilated cardiomyopathy	0.000164	0.000858	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—AGT—dilated cardiomyopathy	0.000162	0.000845	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB1—dilated cardiomyopathy	0.000159	0.00083	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—ANKRD1—dilated cardiomyopathy	0.000156	0.000818	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000155	0.000811	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000153	0.0008	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000152	0.000796	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—TAZ—dilated cardiomyopathy	0.000147	0.000769	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000145	0.00076	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000145	0.000759	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000143	0.00075	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000143	0.000749	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000141	0.00074	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000138	0.000723	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AGTR1—dilated cardiomyopathy	0.000136	0.000709	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—SDHA—dilated cardiomyopathy	0.000133	0.000695	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—AGT—dilated cardiomyopathy	0.000132	0.00069	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000129	0.000677	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—ADRB2—dilated cardiomyopathy	0.000129	0.000673	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAC1—dilated cardiomyopathy	0.000128	0.000669	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—AGT—dilated cardiomyopathy	0.000124	0.000646	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—AGT—dilated cardiomyopathy	0.000122	0.000639	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000117	0.000612	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—RAF1—dilated cardiomyopathy	0.000112	0.000586	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RPS6KB1—dilated cardiomyopathy	0.000111	0.000578	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling by GPCR—EGFR—dilated cardiomyopathy	0.000106	0.000556	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—RAF1—dilated cardiomyopathy	0.000101	0.000528	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAC1—dilated cardiomyopathy	9.99e-05	0.000522	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.96e-05	0.000521	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling by GPCR—EGFR—dilated cardiomyopathy	9.84e-05	0.000515	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—AGT—dilated cardiomyopathy	9.54e-05	0.000499	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—RAF1—dilated cardiomyopathy	9.16e-05	0.000479	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—RAF1—dilated cardiomyopathy	8.58e-05	0.000449	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—RAF1—dilated cardiomyopathy	8.47e-05	0.000443	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—dilated cardiomyopathy	8.11e-05	0.000424	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—CD36—dilated cardiomyopathy	7.9e-05	0.000413	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling by GPCR—EGFR—dilated cardiomyopathy	7.69e-05	0.000402	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism of lipids and lipoproteins—AGT—dilated cardiomyopathy	7.11e-05	0.000372	CbGpPWpGaD
Pentoxifylline—ADORA2B—Signaling Pathways—EGFR—dilated cardiomyopathy	6.92e-05	0.000362	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—RAF1—dilated cardiomyopathy	6.62e-05	0.000346	CbGpPWpGaD
Pentoxifylline—PDE4A—Signaling Pathways—EGFR—dilated cardiomyopathy	6.28e-05	0.000329	CbGpPWpGaD
Pentoxifylline—ADORA1—Signaling Pathways—EGFR—dilated cardiomyopathy	5.88e-05	0.000308	CbGpPWpGaD
Pentoxifylline—PDE4B—Signaling Pathways—EGFR—dilated cardiomyopathy	5.81e-05	0.000304	CbGpPWpGaD
Pentoxifylline—ADORA2A—Signaling Pathways—EGFR—dilated cardiomyopathy	4.54e-05	0.000238	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—GPX1—dilated cardiomyopathy	3.61e-05	0.000189	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—CD36—dilated cardiomyopathy	3.52e-05	0.000184	CbGpPWpGaD
Pentoxifylline—CYP1A2—Metabolism—AGT—dilated cardiomyopathy	3.17e-05	0.000166	CbGpPWpGaD
